Neoadjuvant intent anti-programmed death-1 immunotherapy for cutaneous squamous cell carcinoma in patients with hematologic malignancy

Kyle Murchison, Karam Khaddour, Anthony Camargo, Emily Ruiz, Rosh Sethi, Eleni Rettig, Charles Yoon, Emily Y Kim, Mia DeSimone, Justine Cohen, Nicole R LeBoeuf, Nina Ran, Manisha Thakuria, Ann W Silk

Open source

DOI
10.1093/oncolo/oyag272
Published
2026-07-08
Container
The Oncologist
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyag272,
  title = {Neoadjuvant intent anti-programmed death-1 immunotherapy for cutaneous squamous cell carcinoma in patients with hematologic malignancy},
  author = {Kyle Murchison and Karam Khaddour and Anthony Camargo and Emily Ruiz and Rosh Sethi and Eleni Rettig and Charles Yoon and Emily Y Kim and Mia DeSimone and Justine Cohen and Nicole R LeBoeuf and Nina Ran and Manisha Thakuria and Ann W Silk},
  year = {2026},
  journal = {The Oncologist},
  doi = {10.1093/oncolo/oyag272},
  url = {https://doi.org/10.1093/oncolo/oyag272}
}

RIS

TY  - JOUR
TI  - Neoadjuvant intent anti-programmed death-1 immunotherapy for cutaneous squamous cell carcinoma in patients with hematologic malignancy
AU  - Kyle Murchison
AU  - Karam Khaddour
AU  - Anthony Camargo
AU  - Emily Ruiz
AU  - Rosh Sethi
AU  - Eleni Rettig
AU  - Charles Yoon
AU  - Emily Y Kim
AU  - Mia DeSimone
AU  - Justine Cohen
AU  - Nicole R LeBoeuf
AU  - Nina Ran
AU  - Manisha Thakuria
AU  - Ann W Silk
PY  - 2026
JO  - The Oncologist
DO  - 10.1093/oncolo/oyag272
UR  - https://doi.org/10.1093/oncolo/oyag272
ER  - 

APA

Murchison, K., Khaddour, K., Camargo, A., Ruiz, E., Sethi, R., Rettig, E., Yoon, C., Kim, E. Y., DeSimone, M., Cohen, J., LeBoeuf, N. R., Ran, N., Thakuria, M., & Silk, A. W. (2026). Neoadjuvant intent anti-programmed death-1 immunotherapy for cutaneous squamous cell carcinoma in patients with hematologic malignancy. The Oncologist. https://doi.org/10.1093/oncolo/oyag272

Source records